Skip to main content
Log in

Inhibition of Protein Phosphatase 2A: Focus on the Glutamatergic System

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

In a recent review published in Molecular Neurobiology, Kamat and colleagues (Mol Neurobiol. 2014 Dec;50(3):852–65) highlighted the cellular and molecular mechanisms involved in Okadaic acid (OKA)-induced neurotoxicity. In this review, the authors underline a wide range of pathological signaling pathways involved in OKA-induced neurotoxicity; however, the role of glutamate was only briefly described. We believe that the hyperactivation of the glutamatergic system is a key pathophysiological player in OKA-induced neurotoxicity and deserves serious attention. In this commentary, we propose an integrative model linking glutamate and PP2A and put forward some unanswered questions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K (1993) Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 61(3):921–927

    Article  CAS  PubMed  Google Scholar 

  2. Gong CX, Grundke-Iqbal I, Damuni Z, Iqbal K (1994) Dephosphorylation of microtubule-associated protein tau by protein phosphatase-1 and -2C and its implication in Alzheimer disease. FEBS Lett 341(1):94–98

    Article  CAS  PubMed  Google Scholar 

  3. Iqbal K, Alonso Adel C, Chen S, Chohan MO, El-Akkad E, Gong CX, Khatoon S, Li B et al (2005) Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 1739(2–3):198–210. doi:10.1016/j.bbadis.2004.09.008

    Article  CAS  PubMed  Google Scholar 

  4. Zimmer ER, Leuzy A, Bhat V, Gauthier S, Rosa-Neto P (2014) In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals. Transl Neurodegen 3(1):6. doi:10.1186/2047-9158-3-6

    Article  Google Scholar 

  5. Sontag JM, Sontag E (2014) Protein phosphatase 2A dysfunction in Alzheimer’s disease. Front Mol Neurosci 7:16. doi:10.3389/fnmol.2014.00016

    Article  PubMed  PubMed Central  Google Scholar 

  6. Arif M, Kazim SF, Grundke-Iqbal I, Garruto RM, Iqbal K (2014) Tau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam. Proc Natl Acad Sci U S A 111(3):1144–1149. doi:10.1073/pnas.1322614111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kamat PK, Rai S, Swarnkar S, Shukla R, Nath C (2014) Molecular and cellular mechanism of okadaic acid (OKA)-induced neurotoxicity: a novel tool for Alzheimer’s disease therapeutic application. Mol Neurobiol 50(3):852–865. doi:10.1007/s12035-014-8699-4

    Article  CAS  PubMed  Google Scholar 

  8. Cohen P, Klumpp S, Schelling DL (1989) An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues. FEBS Lett 250(2):596–600

    Article  CAS  PubMed  Google Scholar 

  9. Gong CX, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, Iqbal K (2000) Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer’s disease. J Biol Chem 275(8):5535–5544

    Article  CAS  PubMed  Google Scholar 

  10. Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2005) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Euro J Neurosci 22(8):1942–1950. doi:10.1111/j.1460-9568.2005.04391.x

    Article  Google Scholar 

  11. Zimmer ER, Kalinine E, Haas CB, Torrez VR, Souza DO, Muller AP, Portela LV (2012) Pretreatment with memantine prevents Alzheimer-like alterations induced by intrahippocampal okadaic acid administration in rats. Curr Alzheimer Res 9(10):1182–1190

    Article  CAS  PubMed  Google Scholar 

  12. Kamat PK, Rai S, Swarnkar S, Shukla R, Nath C (2014) Mechanism of synapse redox stress in Okadaic acid (ICV) induced memory impairment: role of NMDA receptor. Neurochem Int 76:32–41. doi:10.1016/j.neuint.2014.06.012

    Article  CAS  PubMed  Google Scholar 

  13. Seo J, Giusti-Rodriguez P, Zhou Y, Rudenko A, Cho S, Ota KT, Park C, Patzke H et al (2014) Activity-dependent p25 generation regulates synaptic plasticity and Abeta-induced cognitive impairment. Cell 157(2):486–498. doi:10.1016/j.cell.2014.01.065

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Robinson DM, Keating GM (2006) Memantine: a review of its use in Alzheimer’s disease. Drugs 66(11):1515–1534

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of Interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luis V. Portela.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zimmer, E.R., Leuzy, A., Souza, D.O. et al. Inhibition of Protein Phosphatase 2A: Focus on the Glutamatergic System. Mol Neurobiol 53, 3753–3755 (2016). https://doi.org/10.1007/s12035-015-9321-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-015-9321-0

Keywords

Navigation